David Rodriguez Czuchlewski MD
Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology
Assistant Professor, Pathology, University of New Mexico School of Medicine
Join to View Full Profile
1001 Woodward Pl NEAlbuquerque, NM 87102
Phone+1 505-938-8467
Are you Dr. Czuchlewski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Czuchlewski, MD is a board certified pathologist in Albuquerque, New Mexico. He is currently licensed to practice medicine in New Mexico, Michigan, and New York. He is an Assistant Professor at University of New Mexico School of Medicine.
Education & Training
University of New Mexico School of MedicineFellowship, Hematopathology, 2007 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2003 - 2007
Icahn School of Medicine at Mount SinaiClass of 2003
Certifications & Licensure
NM State Medical License 2007 - 2027- NM State Medical License 2009 - 2027
MI State Medical License 2021 - 2024
NY State Medical License 2005 - 2010
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 26 citationsSecondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se young Han, Krzysztof Mrózek, Jenna M. Voutsinas, Qian Wu, Elizabeth A. Morgan
Blood Advances. 2021-05-25 - 5 citationsEntrustable Professional Activities in Hematopathology Pathology Fellowship Training: Consensus Design and Proposal.Kristie L. White, Julianne Qualtieri, Elizabeth L Courville, Rose Beck, Bachir Alobeid
Academic Pathology. 2021-02-17 - 5 citationsCore‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failureCelalettin Ustun, Elizabeth A. Morgan, Ethan M. Ritz, Hanne Vestergaard, Sheeja T. Pullarkat
International Journal of Laboratory Hematology. 2021-02-01
